Cargando…

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

OBJECTIVE: No studies have demonstrated the real-world efficacy of antifibrotics for progressive fibrosing interstitial lung disease (PF-ILD). Therefore, we evaluated the efficacy of antifibrotics in patients with PF-ILD. METHODS: We retrospectively reviewed the medical records of patients with ILD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niitsu, Takayuki, Fukushima, Kiyoharu, Komukai, Sho, Takata, So, Abe, Yuko, Nii, Takuro, Kuge, Tomoki, Iwakoshi, Shinichi, Shiroyama, Takayuki, Miyake, Kotaro, Tujino, Kazuyuki, Tanizaki, Satoshi, Iwahori, Kota, Hirata, Haruhiko, Miki, Keisuke, Yanagawa, Masahiro, Takeuchi, Noriyuki, Takeda, Yoshito, Kida, Hiroshi, Kumanogoh, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Treatments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872509/ https://www.ncbi.nlm.nih.gov/pubmed/36690385 http://dx.doi.org/10.1136/rmdopen-2022-002667

Ejemplares similares

Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
por: Shiroyama, Takayuki, et al.
Publicado: (2019)

Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review
por: Niitsu, Takayuki, et al.
Publicado: (2020)

Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema
por: Yamamoto, Yuji, et al.
Publicado: (2022)

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
por: Enomoto, Takatoshi, et al.
Publicado: (2022)

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
por: Tone, Mari, et al.
Publicado: (2023)

A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity
por: Nakagawa, Yuta, et al.
Publicado: (2022)

Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
por: Amiya, Saori, et al.
Publicado: (2021)

COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation
por: Noda, Yoshimi, et al.
Publicado: (2021)

Lateral Decubitus Position Enables Further Advancement of the Bronchoscope into the Lung Periphery
por: Miyake, Kotaro, et al.
Publicado: (2022)

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
por: Iwahori, Kota, et al.
Publicado: (2022)

Pulmonary metastases of lung adenocarcinoma mimicking COVID-19 pneumonia
por: Shiroyama, Takayuki, et al.
Publicado: (2020)

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination
por: Amiya, Saori, et al.
Publicado: (2022)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study
por: Fukushima, Kiyoharu, et al.
Publicado: (2023)

Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID‐19
por: Yamamoto, Yuji, et al.
Publicado: (2023)

Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer
por: Noda, Yoshimi, et al.
Publicado: (2022)

Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan
por: Takata, So, et al.
Publicado: (2022)

Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma
por: Abe, Yuko, et al.
Publicado: (2021)

Pleural Effusion Caused by Mycolicibacterium mageritense in an Immunocompetent Host: A Case Report
por: Niitsu, Takayuki, et al.
Publicado: (2021)

A lung abscess caused by secondary syphilis – the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report
por: Futami, Shinji, et al.
Publicado: (2019)

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report
por: Naito, Maiko, et al.
Publicado: (2023)

Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study
por: Adachi, Yuichi, et al.
Publicado: (2021)

First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease
por: Fukushima, Kiyoharu, et al.
Publicado: (2021)

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
por: Otsuka, Tomoyuki, et al.
Publicado: (2022)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Identifying phenotypes in interstitial lung disease using group-based trajectory modelling
por: Takata, S., et al.
Publicado: (2023)

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
por: Kawamura, Kodai, et al.
Publicado: (2019)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19
por: Iwahori, Kota, et al.
Publicado: (2023)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
por: Osa, Akio, et al.
Publicado: (2019)

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
por: Koba, Taro, et al.
Publicado: (2021)

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19
por: Kawasaki, Takahiro, et al.
Publicado: (2022)

Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
por: Maeda, Yuichi, et al.
Publicado: (2022)

Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense
por: Kuge, Tomoki, et al.
Publicado: (2022)

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
por: Futami, Yu, et al.
Publicado: (2022)

Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing
por: Takata, So, et al.
Publicado: (2022)

Revisiting Cell Death Responses in Fibrotic Lung Disease: Crosstalk between Structured and Non-Structured Cells
por: Fukushima, Kiyoharu, et al.
Publicado: (2020)

The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody
por: Kawasaki, Takahiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e0ged9hur965tk22goerm6uo0b